Zhu Gaohong, Xie Lijun, Miller Daniel
Department of Nuclear Medicine, First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, 650032, China.
School of Computing, University of South Alabama, Mobile, AL, 36688, USA.
Methods Mol Biol. 2017;1617:261-280. doi: 10.1007/978-1-4939-7046-9_19.
MicroRNA (miRNA) are negative regulators of gene expression and subsequent protein production. This method of action translates into regulatory control over cellular processes, including development, signaling, metabolism, and apoptosis. A broad range of miRNA are shown to have abnormal expressions in thyroid cancers which could explain the pathology of tumor oncogenesis and disease progression. A review is conducted of the current research on miRNA dysregulation in thyroid cancers, including papillary thyroid carcinoma (PTC), follicular thyroid carcinoma (FTC), anaplastic thyroid cancer (ATC), and medullary thyroid carcinoma (MTC). Dysregulated miRNA and their associated regulatory pathways are identified and their oncogenic and pathological significance are discussed.
微小RNA(miRNA)是基因表达及后续蛋白质产生的负调控因子。这种作用方式转化为对细胞过程的调控,包括发育、信号传导、代谢和细胞凋亡。大量miRNA在甲状腺癌中呈现异常表达,这可以解释肿瘤发生和疾病进展的病理过程。本文综述了目前关于甲状腺癌(包括乳头状甲状腺癌(PTC)、滤泡状甲状腺癌(FTC)、未分化甲状腺癌(ATC)和髓样甲状腺癌(MTC))中miRNA失调的研究。确定了失调的miRNA及其相关调控途径,并讨论了它们的致癌和病理意义。